These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19326474)

  • 1. Proceedings of the Antiangiogenesis Symposium, October 20-21, 2005. Boston, Massachusetts, USA.
    Angiogenesis; 2005; 8(4):285-379. PubMed ID: 19326474
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the 1st International Conference on Vascular Targeting. Boston, Massachusetts, USA, June 2002.
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1472-536. PubMed ID: 12459372
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiangiogenesis: the fifth cancer treatment modality?
    Camp-Sorrell D
    Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenesis: new frontiers in therapeutic development.
    LaMontagne KR
    Angiogenesis; 2005; 8(4):285-7. PubMed ID: 16400519
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy for antiangiogenesis.
    Kleinman HK; Liau G
    J Natl Cancer Inst; 2001 Jul; 93(13):965-7. PubMed ID: 11438554
    [No Abstract]   [Full Text] [Related]  

  • 6. Translational Research: the Role of VEGF in Tumor Angiogenesis. Proceedings of a symposium. Washington, DC, USA. November 16, 1999.
    Oncologist; 2000; 5 Suppl 1():1-57. PubMed ID: 10804083
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular normalization: study examines how antiangiogenesis therapies work.
    Webb T
    J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
    [No Abstract]   [Full Text] [Related]  

  • 8. Abstracts of the 1st European Conference on Tumor Angiogenesis and Antiangiogenic Therapy. Munich, Germany, 1-3 October 2004.
    Angiogenesis; 2004; 7 Suppl 1():1-53. PubMed ID: 15505925
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International Symposium.
    Harris RE
    IDrugs; 2006 Dec; 9(12):834-6. PubMed ID: 17139568
    [No Abstract]   [Full Text] [Related]  

  • 10. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
    Ribatti D
    Rom J Morphol Embryol; 2008; 49(2):131-5. PubMed ID: 18516317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer.
    O'Reilly MS
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S64-6. PubMed ID: 17848299
    [No Abstract]   [Full Text] [Related]  

  • 12. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic stem cells: a novel tool for the study of antiangiogenesis and tumor-induced angiogenesis.
    Wartenberg M; Dönmez F; Budde P; Sauer H
    Handb Exp Pharmacol; 2006; (174):53-71. PubMed ID: 16370324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
    Folkman J
    Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiogenesis in cancer].
    Pozner RG; Negrotto S; Schattner M
    Medicina (B Aires); 2002; 62(6):604-6. PubMed ID: 12532700
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantation in Hematology and Oncology III: Stem cell potential, cellular therapy, clinical perspectives. Angiogenesis in Oncology and Hematology II: From basic science to clinical studies. September 6-8, 2002, Munster, Germany. Proceedings and abstracts.
    Ann Hematol; 2002; 81 Suppl 2():S3-78. PubMed ID: 12635654
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiogenesis and cancer: recent advances.
    Cáceres W; González S
    P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synergism between Ang-2 and VEGF and its application of anti-angiogenesis in tumor therapy - review].
    He LL; Zhang WJ; Su H; Xu DG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):445-8. PubMed ID: 17493367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis inhibitors: from laboratory to clinical application.
    Nakamura T; Matsumoto K
    Biochem Biophys Res Commun; 2005 Jul; 333(2):289-91. PubMed ID: 15953588
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer.
    Yang F; Jin C; Jiang YJ; Li J; Di Y; Fu DL
    Expert Rev Anticancer Ther; 2011 Apr; 11(4):541-9. PubMed ID: 21504321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.